Navidea Biopharmaceuticals, Inc (NAVB)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:29PM EDT
| Previous close | 0.0380 |
| Open | 0.0350 |
| Bid | 0.0000 x 800 |
| Ask | 0.0000 x 1100 |
| Day's range | 0.0350 - 0.0409 |
| 52-week range | 0.0210 - 0.1720 |
| Volume | |
| Avg. volume | 82,931 |
| Market cap | 3.803M |
| Beta (5Y monthly) | 1.13 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2000 |
| Earnings date | 13 May 2024 - 18 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireNavidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
COLUMBUS, Ohio, January 27, 2024--Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
Business WireNavidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
DUBLIN, Ohio, December 01, 2023--Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
Business WireNavidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock
DUBLIN, Ohio, October 06, 2023--Navidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock
© 2024 Yahoo. All rights reserved.